RABISIN MULTI
RABISIN MULTI
Authorised
- Rabies virus, strain G52, Inactivated
Product identification
Medicine name:
RABISIN MULTI
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Dog
-
Cattle
-
Sheep
-
Ferret
-
Horse
-
Cat
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Dog
- Cattle
- Sheep
- Ferret
- Horse
- Cat
-
Subcutaneous use
- Dog
- Ferret
- Cattle
- Sheep
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- ANSES
Authorisation number:
- FR/V/0933976 5/2010
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
